🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Intracranial Meningioma

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma NCT07150806Phase 1, Phase 21 site📍 Columbus Joshua Palmer · Tests: Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography, Echocardiography Test, Gallium Ga 68-DOTA… Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment NCT06955169Phase 217 sites📍 Irvine📍 La Jolla📍 New Haven RTOG Foundation, Inc. · Tests: [177Lu]Lu-DOTATATE, Standard of Care treatments Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions NCT04343157Phase 21 site📍 San Diego Jona Hattangadi-Gluth · Tests: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS) Intraoperative Brain Shift Calculation Study NCT05477680NA1 site📍 Moscow Sklifosovsky Institute of Emergency Care · Tests: Navigation-guided surgery A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma NCT07428616Phase 220 sites📍 Birmingham📍 Phoenix📍 San Francisco Exelixis · Tests: Zanzalintinib Sonography-guided Resection of Brain Mass Lesions NCT05484245NA1 site📍 Moscow Sklifosovsky Institute of Emergency Care · Tests: Sonography Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 Embolization for Meningioma NCT05416567NA1 site📍 Trondheim St. Olavs Hospital · Tests: Endovascular embolization Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study NCT04278118NA1 site📍 Atlanta Emory University · Tests: Hypofractionated Radiation Therapy, Photon Beam Radiation Therapy, Proton Beam Radiation Therapy, Quality-of-Life Asses… Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors NCT07411690n/a1 site📍 Warsaw Medical University of Warsaw Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma NCT07418775n/a1 site📍 San Francisco University of California, San Francisco · Tests: Questionnaire, Medical Record Review Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas NCT02523014Phase 2784 sites📍 Birmingham📍 Anchorage📍 Anchorage Alliance for Clinical Trials in Oncology · Tests: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, Abemaciclib Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures NCT07413796NA1 site📍 Warsaw Medical University of Warsaw · Tests: Absorbable running intradermal suture, Non-absorbable interrupted transdermal suture
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy